Non-comparative phase II study of bendamustine hydrochloride in patients with pretreated soft tissue sarcoma (German Sarcoma Group-AIO 001).

被引：0
|
作者：
Mayer, F.
Schleicher, J.
Huober, J.
Meisinger, I.
Pintoffl, J.
Kaefer, G.
Gruenwald, V.
Burkart, C.
Kanz, L.
Hartmann, J. T.
机构：
[1] Univ Tuebingen, Tubingen, Germany
[2] Katharinen Hosp, D-70174 Stuttgart, Germany
[3] Krankenhaus Sigmaringen, Sigmaringen, Germany
[4] Hannover Med Sch, D-3000 Hannover, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9525
引用
收藏
页码：526S / 526S
页数：1
相关论文
共 50 条
  • [1] A non-comparative phase II study of pemetrexed in patients with pretreated soft tissue sarcoma: German Sarcoma Group/AIO 005
    Hartmann, J. T.
    Bauer, S.
    Schaedel, S.
    Meisinger, I.
    Bruecher, B. L.
    Kasper, B.
    Kopp, H.
    Kanz, L.
    Mayer, F.
    Gruenwald, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005
    J. T. Hartmann
    S. Bauer
    G. Egerer
    M. S. Horger
    H.-G. Kopp
    V. Grünwald
    F. Mayer
    Investigational New Drugs, 2013, 31 : 167 - 174
  • [3] Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005
    Hartmann, J. T.
    Bauer, S.
    Egerer, G.
    Horger, M. S.
    Kopp, H. -G.
    Gruenwald, V.
    Mayer, F.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (01) : 167 - 174
  • [4] Final analysis of a non-comparative phase II study of multi target enzyme inhibitor pemetrexed in patients with refractory soft tissue sarcoma - German Sarcoma Group AIO 005
    Hartmann, J.
    Bauer, S.
    Schaedel, S.
    Meisinger, I.
    Kasper, B.
    Kopp, H. -G.
    Mayer, F.
    Gruenwald, V.
    ONKOLOGIE, 2010, 33 : 53 - 53
  • [5] Bendamustine hydrochloride in patients with refractory soft tissue sarcoma -: A noncomparative multicenter phase 2 study of the German sarcoma group (AI10-001)
    Hartmann, Joerg T.
    Mayer, Frank
    Schleicher, Jan
    Horger, Marius
    Huober, Jens
    Meisinger, Ines
    Pintoffl, Jan
    Kaefer, Gabriele
    Kanz, Lothar
    Gruenwald, Viktor
    CANCER, 2007, 110 (04) : 861 - 866
  • [6] An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
    Hartmann, JT
    Oechsle, K
    Huober, J
    Jakob, A
    Azemar, M
    Horger, M
    Kanz, L
    Bokemeyer, C
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 249 - 253
  • [7] An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
    J. T. Hartmann
    K. Oechsle
    J. Huober
    A. Jakob
    M. Azemar
    M. Horger
    L. Kanz
    C. Bokemeyer
    Investigational New Drugs, 2006, 24 : 249 - 253
  • [8] An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma
    Peter Reichardt
    Karin Oechsle
    Daniel Pink
    Carsten Bokemeyer
    F. Schneller
    Rolf Issels
    Lothar Kanz
    Jörg Thomas Hartmann
    Investigational New Drugs, 2003, 21 : 481 - 486
  • [9] An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma
    Reichardt, P
    Oechsle, K
    Pink, D
    Bokemeyer, C
    Schneller, F
    Issels, R
    Kanz, L
    Hartmann, JT
    INVESTIGATIONAL NEW DRUGS, 2003, 21 (04) : 481 - 486
  • [10] Exatecan in pretreated adult patients with advanced soft tissue sarcoma:: Results of a phase II -: Study of the EORTC Soft Tissue and Bone Sarcoma Group
    Reichardt, P.
    Nielsen, O. S.
    Bauer, S.
    Hartmann, J. T.
    Schoffski, P.
    Christensen, T. B.
    Pink, D.
    Daugaard, S.
    Marreaud, S.
    van Glabbeke, M.
    Blay, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (06) : 1017 - 1022
12345